Nuzenio

Larimar Therapeutics Reports

Larimar Therapeutics Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Timeline

Tue, 04 Aug 2026 23:29:47 GMTLarimar Therapeutics reports Q2 EPS (30c), consensus (38c) - TipRanks
Tue, 04 Aug 2026 12:02:21 GMTLarimar reports Q2 results and nomlabofusp progress - TipRanks
Tue, 04 Aug 2026 11:21:01 GMTLarimar Therapeutics 2Q 2026: Net loss $32.8M, Diluted EPS $(0.30) — 10-Q Summary - TradingView
Tue, 04 Aug 2026 11:12:46 GMTLarimar Therapeutics (Nasdaq: LRMR) logs $62.4M loss and advances BLA - Stock Titan
Tue, 04 Aug 2026 11:00:00 GMTLarimar Therapeutics Reports Second Quarter 2026 Financial and Business Update - Yahoo Finance
Tue, 04 Aug 2026 07:00:00 GMTLarimar Therapeutics advances nomlabofusp with positive data, rolling FDA submission, and Phase 3 start in 2026 - Pluang

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Larimar Therapeutics Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.